Perioperative cefotetan one-shot prophylaxis in gynecologic/vaginal and abdominal surgery. 1987

R T Michel

UI MeSH Term Description Entries
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013530 Surgical Wound Infection Infection occurring at the site of a surgical incision. Postoperative Wound Infection,Infection, Postoperative Wound,Infection, Surgical Wound,Surgical Site Infection,Wound Infection, Postoperative,Wound Infection, Surgical,Infection, Surgical Site,Infections, Postoperative Wound,Infections, Surgical Site,Infections, Surgical Wound,Postoperative Wound Infections,Surgical Site Infections,Surgical Wound Infections,Wound Infections, Postoperative,Wound Infections, Surgical
D015313 Cefotetan A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. Apacef,Apatef,Cefotan,Cefotetan Disodium,Cefotetan Disodium Salt,Ceftotan,ICI-156834,YM-09330,Disodium Salt, Cefotetan,Disodium, Cefotetan,ICI 156834,ICI156834,Salt, Cefotetan Disodium,YM 09330,YM09330

Related Publications

R T Michel
December 1999, Bratislavske lekarske listy,
R T Michel
September 1989, Minerva ginecologica,
R T Michel
January 1993, Clinical and experimental obstetrics & gynecology,
R T Michel
March 1988, American journal of obstetrics and gynecology,
R T Michel
July 1989, Journal of chemotherapy (Florence, Italy),
R T Michel
August 1984, Revista espanola de las enfermedades del aparato digestivo,
R T Michel
March 2006, American journal of hematology,
R T Michel
March 1988, American journal of obstetrics and gynecology,
Copied contents to your clipboard!